TRY 109.8 billion – 2.8 billion boxes
Size of Turkish pharmaceuticals market as of December 2022.
Biotechnologies Gülfs
USD 2.2 billion
Volume of Turkish pharmaceutical exports in 2023.
68
Number of accredited R&D centers in the Turkish life sciences industry as of November 2024.
2,232
Number of R&D employees in the Turkish pharmaceuticals industry as of 2022.
890%
Growth rate in Turkish pharmaceutical R&D spending between 2013-2022.
Source: www.invest.gov.tr
WHY INVEST IN BIOTECHNOLOGIES SECTOR IN İZMİR?
Favorable demographics with a dynamic, young and skilled talent pool supporting the industry
Heavy investments in healthcare infrastructure and services
Increasing life expectancy and spending in healthcare
Export opportunities due to Türkiye’s proximity to regional markets
Ideal location for clinical trials and a favorable regulatory environment aligned with international standards
Global biotechnologies companies have been present in Türkiye with significant manufacturing activities, using Türkiye as a hub to access regional markets
BIOTECHNOLOGIES COMPANIES IN İZMİR
R&D INFRASTRUCTURES
İBG – İzmir Biomedicine and Genome Center’s mission is to develop innovative technologies and products for the prevention, diagnosis and treatment of diseases using basic research in life sciences as a driving force. İBG houses basic and translational research programs, technological research programs, industrial R&D programs working on biomedicine and genome sciences.
İBG has an enclosed space of approximately 22,250 m2, which includes the research laboratories, cell culture laboratories, equipped rooms for common use.